Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03284307 · ClinicalTrials.gov registry record · Phase 4
UNderstanding CONSciousness Connectedness and Intraoperative Unresponsiveness Study
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT03284307 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 35 participants.
The verdict
NCT03284307, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
This study will be a single-site, controlled, unblinded study at the University of Wisconsin to examine changes in the electroencephalogram during anesthesia and waking.
Interventions
- DRUG Ketamine
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2017-08-10 |
| Est. Completion | 2020-03-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03284307
The ClinicalTrials.gov registry entry for NCT03284307 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Ketamine is the first listed.
NCT03284307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03284307 about?
NCT03284307 is a clinical study titled "UNderstanding CONSciousness Connectedness and Intraoperative Unresponsiveness Study". This study will be a single-site, controlled, unblinded study at the University of Wisconsin to examine changes in the electroencephalogram during anesthesia and waking.
What is the current status of trial NCT03284307?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2017-08-10. Estimated completion is 2020-03-12.
What interventions are being tested in trial NCT03284307?
The interventions under investigation include: Ketamine (DRUG), Midazolam (DRUG), Dexmedetomidine (DRUG), Propofol (DRUG).
Who is sponsoring clinical trial NCT03284307?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.